Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Self-Reported Changes in the Expanded Disability Status Scale (EDSS) Score in Persons with Multiple Sclerosis after Autologous Stem Cell Transplants: Experience with the "Mexican Method"

Guillermo J. Ruiz-Arguelles, FRCP, MACP, Juan Carlos Olivares-Gazca, MD, Iván Murrieta-Álvarez, MD, Jesús Mauricio Olivares-Gazca, MD, Andres Leon-Peña, MD, Yahveth Cantero-Fortiz, MD, Elías Eugenio Gonzalez López, MD, Alejandro Ruiz-Argüelles, MD, Andres Gomez De Leon, MD, David Gomez-Almaguer, MD, Luisa Fernanda Sánchez-Valledor, MD, Yarely Itzayana García-Navarrete, MD, Antonio Cruz-Mora, MD, Guillermo J. Ruiz-Delgado, MD FACP

Blood (2019) 134 (Supplement_1): 2020.

https://doi.org/10.1182/blood-2019-123797

Published: 2019

Journal Articles

Severe Coombs Positive Autoimmune Hemolytic Anemia after Alemtuzumab Infusion for Relapsing Remitting Multiple Sclerosis. What Can We Learn?

Parth Anil Desai, MD, Chase Mathew Romere, MD, Linda Nguyen, MD, Annapurna Saksena, MD, Siddiqui J Abdullah, MD, Adolfo E Diaz, MD

Blood (2018) 132 (Supplement 1): 2331.

https://doi.org/10.1182/blood-2018-99-112724

Published: 2018

Journal Articles

The Hundred-Person Platelet Releasate Project (100PREPs): A Barcode for Human Health and Disease

Patricia Maguire, PhD, Paulina Szklanna, PhD, Martin Parsons, PhD, Kieran Wynne, MSc, Hugh O'Connor, MD, Karen O'Connell, MD, Karl Egan, PhD, Christopher McGuigan, MD PhD, Scott Rickard, PhD, Fionnuala Ni Ainle, MD PhD

Blood (2018) 132 (Supplement 1): 3735.

https://doi.org/10.1182/blood-2018-99-115421

Published: 2018

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Advanced, Treatment Refractory Multiple Sclerosis (MS) — a Phase II Clinical Trial

Jennifer Massey, MBBS, John Moore, MDFRACP,FRCPA,, Ian Sutton, Chun Kei Kris Ma, PhDMBBS, Sam Milliken, FRACP,FRCPA,MBBS, David Ma

Blood (2017) 130 (Supplement 1): 4553.

https://doi.org/10.1182/blood.V130.Suppl_1.4553.4553

Published: 2017

Journal Articles

Successful Treatment of Alemtuzumab Induced Immune Thrombocytopenia with a Thrombopoietin Receptor Agonist

Fathima Mohiyaddin Ayyalil, MBBS, James Slade, BN, GCCaN, MNNP, Daniel Wang, MBBS, James M. D'Rozario, MBBS FRACP FRCPA, Stephen Reddel, MBBS, FRACP, PhD, Philip Young-Ill Choi, BA, BSc, MBBS, PhD FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 2326.

https://doi.org/10.1182/blood.V130.Suppl_1.2326.2326

Published: 2017

Journal Articles

Fingolimod Is Cytotoxic in Acute Myeloid Leukemia Independent of Additional Chemotherapeutic Agents

Carter Thomas Davis, MD, Arati V. Rao, MD, Eross Guadalupe, Dale J. Christensen, PhD, J. Brice Weinberg, MD

Blood (2016) 128 (22): 5126.

https://doi.org/10.1182/blood.V128.22.5126.5126

Published: 2016

Journal Articles

Biological Analysis of SRSF2 Mutations in Leukemogenesis

Manabu Matsunawa, MD, Masashi Sanada, MD, Ryo Yamamoto, MD, PhD, Kenichi Yoshida, MD, Yasunobu Nagata, MD, Ayana Kon, MD, Tetsuichi Yoshizato, MD, Makoto Otsu, MD, PhD, Hiromitsu Nakauchi, MD, PhD, Seishi Ogawa, MD, PhD

Blood (2012) 120 (21): 1282.

https://doi.org/10.1182/blood.V120.21.1282.1282

Published: 2012

Journal Articles

Immune Thrombocytopenia Associated to Low-Dose Alemtuzumab Therapy in Chronic Lymphocytic Leukemia: A Single Retrospective Center Experience

Gianluigi Reda, MD, Francesco Maura, MD, Giuseppe Gritti, MD, Daniele Vincenti, MD, Mariarita Sciumé, MD, Nicola Orofino, MD, Anna Ines Gregorini, MD, Cristina Bucelli, MD, Francesca Binda, MD, Francesca Guidotti, MD, Alfonso Piciocchi, Francesco Rodeghiero, MD, Antonino Neri, Agostino Cortelezzi, MD

Blood (2012) 120 (21): 4598.

https://doi.org/10.1182/blood.V120.21.4598.4598

Published: 2012

Journal Articles

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Richard A. Nash, MD, George J. Hutton, MD, Michael K Racke, MD, Uday R. Popat, M.D., Steven M. Devine, MD, George E. Georges, MD, Linda M. Griffith, MD, PhD, Paolo A Muraro, MD, Harry Openshaw, MD, Peter H. Sayre, MD, PhD, Olaf Stuve, MD, Douglas L Arnold, MD, Meagan Spychala, Noha Lim, PhD, Sachin Malhotra, PhD, Deborah Phippard, PhD, Annette Wundes, MD, George H Kraft, MD, James D Bowen, MD

Blood (2012) 120 (21): 962.

https://doi.org/10.1182/blood.V120.21.962.962

Published: 2012

Journal Articles

Therapeutic Plasma Exchange for Progressive Multifocal Leukoencephalopathy Related to Multiple Sclerosis Therapy with Natalizumab

Eimad Zakariya, MD, Mariko Yabe, MD, Armistead Williams, MD, Randy L. Levine, MD, Mark T Friedman, DO

Blood (2012) 120 (21): 4386.

https://doi.org/10.1182/blood.V120.21.4386.4386

Published: 2012

Journal Articles

A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis

Adam Cuker, Alasdair J. Coles, Herman Sullivan, Edward Fox, Mark Goldberg, Pedro Oyuela, Annie Purvis, Diana S. Beardsley, David H. Margolin

Blood (2011) 118 (24): 6299–6305.

https://doi.org/10.1182/blood-2011-08-371138

Published: 2011

Includes: Supplemental data

Journal Articles

FTY720 Induces Apoptosis and Autophagy in Multiple Myeloma Cells

Aijun Liao, Rong Hu, Qihui Zhao, Huihan Wang, Yingchun Li, Kun Yao, Rong Zhang, Wei Yang, Zhuogang Liu

Blood (2011) 118 (21): 5103.

https://doi.org/10.1182/blood.V118.21.5103.5103

Published: 2011

Journal Articles

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: Early Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Richard A. Nash, MD, George J Hutton, MD, Michael K Racke, MD, Uday R Popat, MD, Steven M. Devine, MD, Linda M. Griffith, MD, PhD, Paolo A Muraro, MD, Harry Openshaw, MD, Peter H. Sayre, MD, PhD, Olaf Stuve, MD, Douglas L Arnold, MD, Lisa Wruck, PhD, Annette Wundes, MD, George H Kraft, MD, James D Bowen, MD

Blood (2011) 118 (21): 3075.

https://doi.org/10.1182/blood.V118.21.3075.3075

Published: 2011

Journal Articles

FTY720 Has Potent Anti-Leukemic Effects on Acute Lymphoblastic Leukemia Cells and Results In Caspase Independent Cell Death

Craig T. Wallington-Beddoe, BSc, MBBS, John Hewson, MBBS, Kenneth Francis Bradstock, MB, PhD, Linda J. Bendall, BSc, PhD

Blood (2010) 116 (21): 3260.

https://doi.org/10.1182/blood.V116.21.3260.3260

Published: 2010

Journal Articles

Reduced Intensity Conditioning Regimens in Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis patients.

Andrei A. Novik, MD, FRCP, Alexey N. Kuznetsov, Vladimir Y Melnichenko, Denis A Fedorenko, Andrey Kartashov, Ruslana V Kruglina, Tatiana I Ionova, Kira Kurbatova, Gary J Gorodokin

Blood (2009) 114 (22): 2317.

https://doi.org/10.1182/blood.V114.22.2317.2317

Published: 2009

Journal Articles

Ott1(Rbm15) Is Essential for Pre-B Differentiation and Has an Inhibitory Role in Myeloid and Megakaryocytic Lineages.

Glen D. Raffel, MD, PhD, Thomas Mercher, Ph.D., Hirokazu Shigematsu, M.D., Ifor R. Williams, M.D., Ph.D., Dana E. Cullen, Koichi Akashi, M.D., Ph.D., Olivier A. Bernard, Ph.D., D. Gary Gilliland, M.D., Ph.D.

Blood (2006) 108 (11): 784.

https://doi.org/10.1182/blood.V108.11.784.784

Published: 2006

Journal Articles

Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Relapsing-Remitting Multiple Sclerosis.

Richard K. Burt, MD, Yu Oyama, MD, Laisvyde Statkute, MD, Kathleen Quigley, RN, Catherine Weppner, RN, Larissa Verda, MD, PhD

Blood (2005) 106 (11): 2930.

https://doi.org/10.1182/blood.V106.11.2930.2930

Published: 2005

Journal Articles

Treatment Outcomes in Multiple Sclerosis (MS) Patients after Early, Conventional and Salvage High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT).

Yury L. Shevchenko, Andrei A. Novik, Boris V. Afanasiev, Igor A. Lisukov, Tatiana I. Ionova, PhD, Andrei D. Kulagin, MD, Olga A. Malysheva, MD, Gennady N. Bisaga, MD, PhD, Vladimir J. Melnichenko, MD, PhD, Sergei V. Voloshin, MD, PhD, Denis A. Fedorenko, MD, PhD, Inna V. Vereschagina, MD, Anton V. Kishtovich, PhD, Yury N. Fedotov, MD, PhD, Gary I. Gorodokin, MD

Blood (2005) 106 (11): 5467.

https://doi.org/10.1182/blood.V106.11.5467.5467

Published: 2005

Journal Articles

High prevalence of autoreactive, neuroantigen-specific CD8 + T cells in multiple sclerosis revealed by novel flow cytometric assay

Michael P. Crawford, Shirley X. Yan, Sterling B. Ortega, Riyaz S. Mehta, Rachel E. Hewitt, David A. Price, Peter Stastny, Daniel C. Douek, Richard A. Koup, Michael K. Racke, Nitin J. Karandikar

Blood (2004) 103 (11): 4222–4231.

https://doi.org/10.1182/blood-2003-11-4025

Published: 2004

Journal Articles

ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis

Enrico Garattini, Edoardo Parrella, Luisa Diomede, Maurizio Gianni', Yesim Kalac, Lucio Merlini, Daniele Simoni, Romina Zanier, Fabiana Fosca Ferrara, Ilaria Chiarucci, Paolo Carminati, Mineko Terao, Claudio Pisano

Blood (2004) 103 (1): 194–207.

https://doi.org/10.1182/blood-2003-05-1577

Published: 2004

NARROW

Self-Reported Changes in the Expanded Disability Status Scale (EDSS) Score in Persons with Multiple Sclerosis after Autologous Stem Cell Transplants: Experience with the "Mexican Method"

Severe Coombs Positive Autoimmune Hemolytic Anemia after Alemtuzumab Infusion for Relapsing Remitting Multiple Sclerosis. What Can We Learn?

The Hundred-Person Platelet Releasate Project (100PREPs): A Barcode for Human Health and Disease

Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Advanced, Treatment Refractory Multiple Sclerosis (MS) — a Phase II Clinical Trial

Successful Treatment of Alemtuzumab Induced Immune Thrombocytopenia with a Thrombopoietin Receptor Agonist

Fingolimod Is Cytotoxic in Acute Myeloid Leukemia Independent of Additional Chemotherapeutic Agents

Biological Analysis of SRSF2 Mutations in Leukemogenesis

Immune Thrombocytopenia Associated to Low-Dose Alemtuzumab Therapy in Chronic Lymphocytic Leukemia: A Single Retrospective Center Experience

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Therapeutic Plasma Exchange for Progressive Multifocal Leukoencephalopathy Related to Multiple Sclerosis Therapy with Natalizumab

A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis

FTY720 Induces Apoptosis and Autophagy in Multiple Myeloma Cells

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: Early Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

FTY720 Has Potent Anti-Leukemic Effects on Acute Lymphoblastic Leukemia Cells and Results In Caspase Independent Cell Death

Reduced Intensity Conditioning Regimens in Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis patients.

Ott1(Rbm15) Is Essential for Pre-B Differentiation and Has an Inhibitory Role in Myeloid and Megakaryocytic Lineages.

Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Relapsing-Remitting Multiple Sclerosis.

Treatment Outcomes in Multiple Sclerosis (MS) Patients after Early, Conventional and Salvage High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT).

High prevalence of autoreactive, neuroantigen-specific CD8 + T cells in multiple sclerosis revealed by novel flow cytometric assay

ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only